European drugmakers are urging the EU to allow higher medicine prices, warning that without stronger investment incentives, ...

By Maggie Fick LONDON (Reuters) -AstraZeneca Chief Executive Officer Pascal Soriot said on Wednesday that just like Europe ...

Tumor-infiltrating clonal hematopoiesis (TI-CH) increased the risk of disease recurrence or death among patients with early ...

The dipeptidyl peptidase 1 (DPP-1) inhibitor cut the annualized rate of pulmonary exacerbations by around 20% compared with ...

In what could be seen as a bellwether for the pharmaceutical industry's sweeping shift toward localised manufacturing—spurred ...

Granite will focus on two antibody therapies, both targeting crucial players in the inflammatory cascade to address ...

Pharma executives emphasise that without urgent action, Europe may face a decline and an acceleration in the departure of ...

Granite Bio is ready to rock ‘n’ roll, unveiling with $100 million and hopes of shaping new antibody treatments targeting ...

A high cholesterol sufferer has told English cricket legend Mark Ramprakash about changes he has made to his lifestyle after ...

Held during Abu Dhabi Global Health Week, the roundtable united global health leaders to shape a Declaration on AI governance ...

Crispr Therapeutics is an emerging gene editing company focused on the development of Crispr/Cas9-based therapeutics. The company's proprietary platform specializes in clustered regularly interspaced ...

Firm CEO Vince Guglielmotti said strong performances in all five of the firm’s main practice areas helped continue its steady ...